Just following the research of Prof Shinya Yamanaka at Kyoto University in Japan, Wilmut “believes a rival method pioneered in Japan has better potential for making human embryonic cells which can be used to grow a patient’s own cells and tissues for a vast range of treatments, from treating strokes to heart attacks and Parkinson’s, and will be less controversial than the Dolly method, known as “nuclear transfer”.”
Kyoto University has steered away from cloning research because it is ethically problematic, requires human eggs and inefficient and to date unsuccessful.
- Jennifer Lahl, MA, BSN, RN, is founder and president of The Center for Bioethics and Culture Network. Lahl couples her 25 years of experience as a pediatric critical care nurse, a hospital administrator, and a senior-level nursing manager with a deep passion to speak for those who have no voice. Lahl’s writings have appeared in various publications including Cambridge University Press, the San Francisco Chronicle, the Dallas Morning News, and the American Journal of Bioethics. As a field expert, she is routinely interviewed on radio and television including ABC, CBS, PBS, and NPR. She is also called upon to speak alongside lawmakers and members of the scientific community, even being invited to speak to members of the European Parliament in Brussels to address issues of egg trafficking; she has three times addressed the United Nations during the Commission on the Status of Women on egg and womb trafficking.